|
|
| eLearning Home / Course Listing / Course Detail |
|
Need Access? If you would like to subscribe your organization to our online course catalog,
please click here.
Already Have Access? If your login allows you direct access to our online course catalog,
please log in now.
ACHPR Evidence Report/Technology Assessment: Number 7 Treatment of Depression-Newer Pharmacotherapies - Summary
The ultimate purpose of this report is to help clinicians make informed choices about newer antidepressant drugs and herbal therapies, and to aid organizations developing clinical guidelines for the treatment of depression. The report provides a comprehensive evaluation of the benefits and adverse effects of newer pharmacotherapies and herbal treatments for depressive disorders in adults and children.
Keywords: Pharmacology, pharmacotherapy, medication, clinical guideline, psychotherapy, alternative medicine, natural treatment, major depression, dysthymia, subsyndromal depression
|
Approval Bodies:
- Professional Development
- American Psychological Association
- Florida Dept. of Health (Board of Social Work, Marriage & Family, Mental Health Counseling)
- Florida Board of Nursing
- California Board of Nursing
- CAADAC, California Association of Alcoholism and Drug Abuse Counselors
- CAADE - California Association for Alcohol/Drug Educators
- Illinois Social Work Continuing Education
- Association of Social Work Boards Approved Continuing Education (ACE)
- NAADAC, National Association for Addiction Professionals
- National Board for Certified Counselors
- Ohio Board of Counselor, Social Worker and Marriage and Family Therapist Board
- California Board of Behavioral Sciences
- Illinois Department of Professional Regulation
- Alabama State Board of Social Work Examiners
- Texas Board of Examiners of Marriage and Family Therapists
|
|